Rate Video

iwCLL 2019 | Clinical impact of ATM and TP53 mutations in mantle cell lymphoma

Jitka Malčíková

iwCLL 2019

Lymphoma Mantle Cell Lymphoma

Jitka Malčíková, PhD, Masaryk University, Brno, Czech Republic, talks about a paper recently published in Leukemia & Lymphoma on ataxia-telangiectasia mutated (ATM) and TP53 mutations in mantle cell lymphoma. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Minor-clone mutations in CLL patients entering first-line treatment

Jitka Malčíková

Current knowledge of the TP53 mutation and its role in CLL

Jitka Malčíková • 25 Oct 2018

Related Videos

Key challenges of using the intestinal microbiome as a biomarker

CAR T-cell therapy: the importance of LTFU

CD19 CAR T-cell therapy for lymphoma

Michael Schmitt

Axicabtagene ciloleucel in the real-world: safety and efficacy